These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33493091)

  • 41. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.
    Huang LS; Fu P; Patel P; Harijith A; Sun T; Zhao Y; Garcia JG; Chun J; Natarajan V
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):912-22. PubMed ID: 23808384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
    Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Qualitative rather than quantitative changes are hallmarks of fibroblasts in bleomycin-induced pulmonary fibrosis.
    Tsukui T; Ueha S; Abe J; Hashimoto S; Shichino S; Shimaoka T; Shand FH; Arakawa Y; Oshima K; Hattori M; Inagaki Y; Tomura M; Matsushima K
    Am J Pathol; 2013 Sep; 183(3):758-73. PubMed ID: 23886891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple Fibroblast Subtypes Contribute to Matrix Deposition in Pulmonary Fibrosis.
    Liu X; Dai K; Zhang X; Huang G; Lynn H; Rabata A; Liang J; Noble PW; Jiang D
    Am J Respir Cell Mol Biol; 2023 Jul; 69(1):45-56. PubMed ID: 36927333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-delivery of siPTPN13 and siNOX4
    Hou J; Ji Q; Ji J; Ju S; Xu C; Yong X; Xu X; Muddassir M; Chen X; Xie J; Han X
    Theranostics; 2021; 11(7):3244-3261. PubMed ID: 33537085
    [No Abstract]   [Full Text] [Related]  

  • 48. IRAK-M promotes alternative macrophage activation and fibroproliferation in bleomycin-induced lung injury.
    Ballinger MN; Newstead MW; Zeng X; Bhan U; Mo XM; Kunkel SL; Moore BB; Flavell R; Christman JW; Standiford TJ
    J Immunol; 2015 Feb; 194(4):1894-904. PubMed ID: 25595781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-surface phenotyping identifies CD36 and CD97 as novel markers of fibroblast quiescence in lung fibrosis.
    Heinzelmann K; Lehmann M; Gerckens M; Noskovičová N; Frankenberger M; Lindner M; Hatz R; Behr J; Hilgendorff A; Königshoff M; Eickelberg O
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L682-L696. PubMed ID: 29952218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
    Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
    Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
    Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RNA-sequencing reveals differential fibroblast responses to bleomycin and pneumonectomy.
    Wellmerling JH; Dresler SR; Meridew JA; Choi KM; Tschumperlin DJ; Tan Q
    Physiol Rep; 2024 Jul; 12(13):e16148. PubMed ID: 38991987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis.
    Li JM; Chang WH; Li L; Yang DC; Hsu SW; Kenyon NJ; Chen CH
    Respir Res; 2023 May; 24(1):132. PubMed ID: 37194070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of MT1-MMP in Alveolar Epithelial Cells Exacerbates Pulmonary Fibrosis.
    Placido L; Romero Y; Maldonado M; Toscano-Marquez F; Ramírez R; Calyeca J; Mora AL; Selman M; Pardo A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNA H19 deficiency ameliorates bleomycin-induced pulmonary inflammation and fibrosis.
    Wan X; Tian X; Du J; Lu Y; Xiao Y
    Respir Res; 2020 Nov; 21(1):290. PubMed ID: 33138822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway.
    Chen Y; Zhang Q; Zhou Y; Yang Z; Tan M
    Hum Exp Toxicol; 2020 May; 39(5):683-695. PubMed ID: 31884830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. S100a4 Is Secreted by Alternatively Activated Alveolar Macrophages and Promotes Activation of Lung Fibroblasts in Pulmonary Fibrosis.
    Zhang W; Ohno S; Steer B; Klee S; Staab-Weijnitz CA; Wagner D; Lehmann M; Stoeger T; Königshoff M; Adler H
    Front Immunol; 2018; 9():1216. PubMed ID: 29910813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis.
    Wiley CD; Brumwell AN; Davis SS; Jackson JR; Valdovinos A; Calhoun C; Alimirah F; Castellanos CA; Ruan R; Wei Y; Chapman HA; Ramanathan A; Campisi J; Jourdan Le Saux C
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31687975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis.
    Bartis D; Crowley LE; D'Souza VK; Borthwick L; Fisher AJ; Croft AP; Pongrácz JE; Thompson R; Langman G; Buckley CD; Thickett DR
    BMC Pulm Med; 2016 Apr; 16(1):51. PubMed ID: 27080864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.